Anti-Platelet Factor 4 Antibody Clonal Heterogeneity and MGUS Status in HIT

Area of Science:

• Immunology
• Hematology
• Thrombosis Research

Background:

• Monoclonal gammopathy of thrombotic significance (MGTS) is a prothrombotic condition linked to monoclonal anti-PF4 antibodies.
• Heparin-induced thrombocytopenia (HIT) also involves anti-PF4 antibodies, but their clonality and relation to MGUS are debated.
• Previous studies show conflicting data regarding antibody clonality in HIT.

Purpose of the Study:

• To evaluate the clonality and abundance of anti-PF4 antibodies in patients with HIT.
• To determine if MGUS in HIT patients represents the causative anti-PF4 antibody.

Main Methods:

• Analysis of blood samples from 15 HIT patients using PF4-dependent antigen-based and functional tests.
• Mass spectrometric evaluation of the serum antibody repertoire and isolated anti-PF4 antibodies.
• Assessment of antibody clonality through analysis of deglycosylated antibody heavy chains.

Main Results:

• Two of 15 HIT patients had an IgG MGUS, but the MGUS antibody was not the anti-PF4 antibody.
• Eight patients showed monoclonal anti-PF4 antibodies, though none were detectable as MGUS due to low abundance.
• Multiple anti-PF4 antibodies in seven patients were confirmed as non-monoclonal.

Conclusions:

• Anti-PF4 antibodies in HIT are monoclonal in about 50% of cases but are typically present at low levels, below the MGUS detection threshold.
• This low abundance differentiates HIT from MGTS, where antibodies are more abundant and detectable as MGUS.
• The findings help explain the transient nature of HIT compared to the persistent prothrombotic state in MGTS.